A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases
- PMID: 2929811
- PMCID: PMC1349984
- DOI: 10.2105/ajph.79.4.495
A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases
Abstract
An epidemiologic classification of paralytic poliomyelitis cases (ECPPC) has been in use in the United States since 1976. In 1985, this classification system was reviewed because of recent changes in the epidemiology of paralytic poliomyelitis and improved laboratory capability to definitively characterize poliovirus strains. An alternative classification system was devised, the epidemiologic and laboratory classification of paralytic polio cases (ELCPPC), that incorporated virus isolation and strain characterization with epidemiologic information. Reported paralytic poliomyelitis cases for 1980-86 were classified by both the ECPPC and the ELCPPC classification systems. The new ELCPPC system classified 91 per cent of the reported cases as vaccine-associated, while the ECPPC system classified only 71 per cent of the reported cases as vaccine-associated. The proposed classification system provides more specific and useful information particularly concerning vaccine-associated paralytic poliomyelitis.
Similar articles
-
Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection.Am J Epidemiol. 1994 Dec 15;140(12):1111-24. doi: 10.1093/oxfordjournals.aje.a117211. Am J Epidemiol. 1994. PMID: 7998593
-
Vaccine policy changes and epidemiology of poliomyelitis in the United States.JAMA. 2004 Oct 13;292(14):1696-701. doi: 10.1001/jama.292.14.1696. JAMA. 2004. PMID: 15479934
-
Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.Cent Eur J Public Health. 2003 Dec;11(4):213-8. Cent Eur J Public Health. 2003. PMID: 14768785
-
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease.Clin Infect Dis. 1992 Feb;14(2):568-79. doi: 10.1093/clinids/14.2.568. Clin Infect Dis. 1992. PMID: 1554844 Review.
-
Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.Expert Rev Vaccines. 2012 May;11(5):609-28. doi: 10.1586/erv.12.28. Expert Rev Vaccines. 2012. PMID: 22827246 Review.
Cited by
-
The effect of diarrheal disease on bivalent oral polio vaccine (bOPV) immune response in infants in Nepal.Vaccine. 2016 May 11;34(22):2519-26. doi: 10.1016/j.vaccine.2016.03.027. Epub 2016 Apr 13. Vaccine. 2016. PMID: 27085172 Free PMC article. Clinical Trial.
-
High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis.J Virol. 1994 Dec;68(12):8089-101. doi: 10.1128/JVI.68.12.8089-8101.1994. J Virol. 1994. PMID: 7966599 Free PMC article. Clinical Trial.
-
Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.J Virol. 1997 Oct;71(10):7758-68. doi: 10.1128/JVI.71.10.7758-7768.1997. J Virol. 1997. PMID: 9311861 Free PMC article.
-
Application of monoclonal antibody panels in the virological and epidemiological review of poliomyelitis in Poland, 1981-1990.Bull World Health Organ. 1992;70(3):327-33. Bull World Health Organ. 1992. PMID: 1322249 Free PMC article.
-
Fifty Years of Global Immunization at CDC, 1966-2015.Public Health Rep. 2017 Jan/Feb;132(1):18-26. doi: 10.1177/0033354916681490. Epub 2016 Dec 19. Public Health Rep. 2017. PMID: 28005470 Free PMC article. No abstract available.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical